RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.

RNTZ

SKK Holdings Limited

There isn't enough reported data to score RNTZ yet.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

RNTZ Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Weak

RNTZ's profitability and balance sheet are currently weak. There isn't enough data to rate its revenue and cash flow.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

RNTZ PE Valuation

RNTZ has no meaningful PE right now: it lost money over the past year.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

RNTZ Forward outlook

There aren't enough analyst estimates for RNTZ to show an outlook.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

There is not enough scenario data to compare RKLB and RNTZ's risk to reward.

RNTZ Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $4.87 on Nov 12.

There is not enough scenario data to compare RKLB and RNTZ's risk to reward.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB has the edge over RNTZ in the latest year-over-year earnings comparison.

RNTZ Earnings Per Share

Q4 2022: $1.04Q1 2023: $0.89Q2 2023: $0.74Q3 2023: $0.44Q4 2023: $0.14Q4 2024: $0.30Q4 2025: $-1.60
Q4 2022: $1.04Q1 2023: $0.89Q2 2023: $0.74Q3 2023: $0.44Q4 2023: $0.14Q4 2024: $0.30Q4 2025: $-1.60
QuarterTTM EPSYoY
Q4 2025-$1.60-633%
Q4 2024$0.30+114%
Q4 2023$0.14-87%

RNTZ has swung to a loss: it lost $1.60 per share over the past year, after a profit the year before.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RNTZ has the stronger quarterly revenue trend. Revenue is up 73% for RKLB versus up 462% for RNTZ.

RNTZ Quarterly Revenue

Q1 2022: $2MQ2 2022: $2MQ3 2022: $2MQ4 2022: $2MQ1 2023: $3MQ2 2023: $3MQ3 2023: $2MQ4 2023: $2MQ4 2024: $11MQ2 2025: $6MQ4 2025: $13M
Q1 2022: $2MQ2 2022: $2MQ3 2022: $2MQ4 2022: $2MQ1 2023: $3MQ2 2023: $3MQ3 2023: $2MQ4 2023: $2MQ4 2024: $11MQ2 2025: $6MQ4 2025: $13M
QuarterRevenueYoY
Q4 2025$12.9M+15%
Q4 2024$11.3M+411%
Q4 2023$2.2M-6.1%
Q3 2023$2.3M-2.1%
Q2 2023$2.6M+4.8%
Q1 2023$2.6M+4.8%

RNTZ's revenue is growing: $13M last quarter, up 462% from the same quarter a year ago.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

RNTZ Free Cash Flow

Q1 2022: --Q2 2022: --Q3 2022: --Q4 2022: --Q1 2023: --Q2 2023: --Q3 2023: --Q4 2023: --Q4 2024: −$4MQ2 2025: −$4MQ4 2025: −$6M
Q1 2022: --Q2 2022: --Q3 2022: --Q4 2022: --Q1 2023: --Q2 2023: --Q3 2023: --Q4 2023: --Q4 2024: −$4MQ2 2025: −$4MQ4 2025: −$6M
QuarterFree cash flowYoY
Q4 2025-$5.6M-$1.2M

RNTZ and RKLB do not have enough comparable growth data to identify a winner.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has the edge over RNTZ on shareholder dilution, with a more favorable share count trend.

RNTZ Total Shares

Q1 2022: 1MQ2 2022: 1MQ3 2022: 1MQ4 2022: 1MQ1 2023: 1MQ2 2023: 1MQ3 2023: 1MQ4 2023: 1MQ4 2024: 2MQ2 2025: 2MQ4 2025: 2M
Q1 2022: 1MQ2 2022: 1MQ3 2022: 1MQ4 2022: 1MQ1 2023: 1MQ2 2023: 1MQ3 2023: 1MQ4 2023: 1MQ4 2024: 2MQ2 2025: 2MQ4 2025: 2M
PeriodChange %Net change
Quarterly0%--
1 year+35%+488K shares

RNTZ has 2M diluted shares, up 35% from a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

RNTZ Net Leverage

Q4 2022: 1.1xQ2 2023: 1.6xQ4 2023: 4.1x
Q4 2022: 1.1xQ2 2023: 1.6xQ4 2023: 4.1x
QuarterNet LeverageStatus
Q4 20234.1xHigh
Q2 20231.6xHealthy
Q4 20221.1xHealthy

RNTZ's net debt is about 4.1 years of its operating earnings (EBITDA).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

RNTZ Weekly Momentum

MetricValueStatus
RSI55.3Neutral
Stochastic10.7Oversold

RNTZ's weekly RSI is 55 (neutral) and its Stochastic is 11 (oversold).

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

RNTZ PE vs Industrials Sector

MetricRNTZSector medianRelative
PEN/A24x—

RNTZ has no meaningful PE right now: it lost money over the past year.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RNTZ has stronger trend alignment. RKLB is above 3 of 5 weekly averages versus RNTZ above 3 of 4.

RNTZ Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.469.2% above
20 week MA$4.576.6% above
50 week MA$3.7630% above
100 week MA$5.124.9% below

RNTZ has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 4.9% below its 100-week average.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

RNTZ Yearly ROI

YearStart priceEnd priceROI
2024$28.0$13.1-53%
2025$13.1$2.80-79%
2026 YTD$2.80$4.87+74%

RNTZ has the edge over RKLB on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key